General
Peptide: | R-FV-I16 |
Microorganism: | Escherichia coli ATCC 25922 |
Administration: | |
Stage: | Formation (3-24h) |
Notes: |
Experimental procedure
Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
---|---|---|---|
Crystal violet assay | 21 - 50% | 0.5 uM | |
Crystal violet assay | 21 - 50% | 0.25 uM |
Reference
- Wei Xu, Xin Zhu, Tingting Tan, Weizhong Li, Anshan Shan Design of Embedded-Hybrid Antimicrobial Peptides with Enhanced Cell Selectivity and Anti-Biofilm Activity
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com